(BCAB) Bioatla - Performance -69.4% in 12m
BCAB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-86.88%
#162 in Peer-Group
Rel. Strength
4.70%
#7335 in Stock-Universe
Total Return 12m
-69.44%
#163 in Peer-Group
Total Return 5y
-98.75%
#177 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 2.37 USD |
| 52 Week Low | 0.27 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 48.17 |
| Buy/Sell Signal +-5 | -1.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BCAB (-69.4%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BCAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BCAB
| Total Return (including Dividends) | BCAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -23.56% | 0.53% | 3.75% |
| 3 Months | 45.52% | 21.37% | 25.32% |
| 12 Months | -69.44% | -9.11% | 13.11% |
| 5 Years | -98.75% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | BCAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -81.3% | -5.7% | 80.3% |
| 3 Months | 16.5% | 79.4% | 97.2% |
| 12 Months | -79.6% | -86.9% | 45.4% |
| 5 Years | -93.5% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th8.00 | -23.96% | -26.32% |
| 3 Month | %th70.00 | 19.90% | 16.12% |
| 12 Month | %th19.00 | -66.38% | -72.98% |
| 5 Years | %th13.50 | -97.87% | -99.30% |
FAQs
Does Bioatla (BCAB) outperform the market?
No,
over the last 12 months BCAB made -69.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months BCAB made 45.52%, while XBI made 21.37%.
Performance Comparison BCAB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BCAB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.2% | -27.3% | -36.6% | -83% |
| US NASDAQ 100 | QQQ | -1.7% | -27.8% | -38.2% | -81% |
| German DAX 40 | DAX | -3% | -23.8% | -49.3% | -100% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.3% | -27.3% | -40.3% | -91% |
| Hongkong Hang Seng | HSI | -0.7% | -26.6% | -57.1% | -108% |
| India NIFTY 50 | INDA | -0.5% | -24.4% | -37.1% | -68% |
| Brasil Bovespa | EWZ | -0.5% | -29.4% | -58.6% | -77% |
BCAB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.2% | -27.1% | -41.1% | -94% |
| Consumer Discretionary | XLY | -0.5% | -25.6% | -28.8% | -85% |
| Consumer Staples | XLP | 0% | -24% | -37.1% | -77% |
| Energy | XLE | -4.3% | -30.3% | -32.9% | -72% |
| Financial | XLF | 0.1% | -26.3% | -39.1% | -97% |
| Health Care | XLV | 0.5% | -24.7% | -27.6% | -65% |
| Industrial | XLI | -1.3% | -26.7% | -43.5% | -94% |
| Materials | XLB | -2% | -27.3% | -40.2% | -75% |
| Real Estate | XLRE | -0.1% | -23.4% | -35.5% | -81% |
| Technology | XLK | -2.9% | -30.7% | -40.7% | -80% |
| Utilities | XLU | 0.2% | -24.8% | -39% | -91% |
| Aerospace & Defense | XAR | -1.9% | -27.3% | -54.8% | -117% |
| Biotech | XBI | -2.7% | -24.1% | -22.5% | -60% |
| Homebuilder | XHB | 0.1% | -29.6% | -28.7% | -73% |
| Retail | XRT | -1.3% | -25.1% | -31.9% | -79% |
BCAB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.8% | -30.4% | -30.3% | -65% |
| Natural Gas | UNG | 1.1% | -13.1% | -17.4% | -63% |
| Gold | GLD | 0.4% | -22.8% | -54.4% | -109% |
| Silver | SLV | -2.5% | -23.3% | -52.2% | -88% |
| Copper | CPER | -7.7% | -33.6% | -57% | -88% |
BCAB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.7% | -24.6% | -32.9% | -66% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -24.9% | -35% | -79% |